Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 34, 2015 - Issue 3
Submit an article Journal homepage
93
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Virologic and genetic evaluation of vemurafenib-induced skin cancers

Emi DikaDermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy, Correspondence[email protected]
,
Annalisa PatriziDermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy,
,
Annalisa AltimariLaboratory of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, Italy,
,
Michelangelo FiorentinoLaboratory of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, Italy,
,
Michelangelo La PlacaDermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy,
,
Elisa GruppioniLaboratory of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, Italy,
,
Simona VenturoliDivision of Microbiology, Department of Haematology, Oncology and Laboratory Medicine, Unit of Microbiology, S. Orsola-Malpighi University Hospital, Bologna, Italy, and
,
Sabina VaccariDermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy,
,
Barbara MelottiDivision of Oncology, Department of Haematology, Oncology and Laboratory Medicine, Unit of Microbiology, S. Orsola-Malpighi University Hospital, Bologna, Italy
,
Bianca Maria PiracciniDermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy,
&
Pier Alessandro FantiDermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy,
show all
Pages 251-253 | Received 24 Apr 2014, Accepted 24 Jul 2014, Published online: 08 Sep 2014
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

We describe the occurrence of a giant squamous cell carcinoma in a patient receiving vemurafenib for the treatment of late melanoma mestastases. Although the development of keratoacanthomas and squamous cell carcinomas (SCC) has been described during vemurafenib therapy, most of the reported cases are treated with surgical excision. In the present case, SCC regressed after drug withdrawal.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,568.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.